AIMEI HEALTH TECHNOLOGY CO

AFJKNASDAQ

🏆 #3804 by market capEarnings Aug 12US Equity

$12.01▲ $0.05 (+0.42%)

🌅 Pre-market$11.84▼ 1.42%Regular close · extended-hours price shown

1h—

24h▲ 0.4%

7d▲ 0.4%

14d▲ 0.4%

30d▼ 8.7%

1y▲ 7.7%

🏦Market Cap

$38M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

Trading Snapshot

Day Range: $11.87 – $12.22
52-Week Range: $6.75 – $130.37
Volume: $2.48B
Avg Volume: $2.89B
Shares Outstanding: 3.2M
Next Earnings: Sep 23, 2026

Fundamentals Snapshot

Annual Revenue: $7M
Last Q Revenue: $2M
P/E Ratio: 41.1
P/S Ratio: —
EPS (TTM): $0.17
Dividend Yield: —

Why Investors Own AFJK

✓High-growth profile — revenue up +10.0% YoY with expanding US Equity exposure.
✓Healthy economics — 58% gross margin and 5% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$7M▲ +9.4% YoY

Gross Margin (TTM)

57.6%▲ +0.7% YoY

Operating Income (TTM)

$636,969▲ +9.4% YoY

Free Cash Flow (TTM)

$395,360▲ +9.4% YoY

About AIMEI HEALTH TECHNOLOGY CO

Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.

🦦